BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 10856322)

  • 21. The anti-inflammatory activity of glucocorticoids.
    de Waal RM
    Mol Biol Rep; 1994 Mar; 19(2):81-8. PubMed ID: 8072494
    [No Abstract]   [Full Text] [Related]  

  • 22. Current issues of basic and clinical glucocorticoid research.
    Buttgereit F
    Clin Exp Rheumatol; 2003; 21(2):145-7. PubMed ID: 12747266
    [No Abstract]   [Full Text] [Related]  

  • 23. Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation.
    Anderson GP
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 2):S188-96. PubMed ID: 10712373
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis.
    Strehl C; van der Goes MC; Bijlsma JW; Jacobs JW; Buttgereit F
    Expert Opin Investig Drugs; 2017 Feb; 26(2):187-195. PubMed ID: 28043173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Corticosteroid therapy of asthma].
    Chanez P; Vachier I; Michel FB; Bousquet J; Godard P
    Presse Med; 2000 Sep; 29(16):1469-78. PubMed ID: 11039095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.
    Goulding NJ
    Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucocorticoid receptor modulators CpdX and CpdX-D3 exhibit the same in vivo antiinflammatory activities as synthetic glucocorticoids.
    Hua G; Zein N; Daubeuf F; Chambon P
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14191-14199. PubMed ID: 31227605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosstalk between TNF and glucocorticoid receptor signaling pathways.
    Van Bogaert T; De Bosscher K; Libert C
    Cytokine Growth Factor Rev; 2010 Aug; 21(4):275-86. PubMed ID: 20456998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular mechanisms of anti-inflammatory actions of glucocorticoids and their synergy with beta2-agonists].
    Obojski A; Kraus-Filarska M
    Pol Arch Med Wewn; 2004 Jun; 111(6):743-7. PubMed ID: 15508799
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches.
    Marwick JA; Adcock IM; Chung KF
    Drugs; 2010 May; 70(8):929-48. PubMed ID: 20481652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid resistance in asthma. Molecular mechanisms.
    Adcock IM
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 2):S58-61. PubMed ID: 8756790
    [No Abstract]   [Full Text] [Related]  

  • 33. Design, synthesis, and local anti-inflammatory activity of 17β-carboxamide derivatives of glucocorticoids.
    Dobričić V; Marković B; Milenković N; Savić V; Jaćević V; Rančić N; Vladimirov S; Cudina O
    Arch Pharm (Weinheim); 2014 Nov; 347(11):786-97. PubMed ID: 25159891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The multiple facets of glucocorticoid action in rheumatoid arthritis.
    Baschant U; Lane NE; Tuckermann J
    Nat Rev Rheumatol; 2012 Nov; 8(11):645-55. PubMed ID: 23045254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of steroid action in asthma.
    Barnes PJ
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 2):159-68. PubMed ID: 8568147
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeting inflammation using selective glucocorticoid receptor modulators.
    De Bosscher K; Haegeman G; Elewaut D
    Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.
    Vayssière BM; Dupont S; Choquart A; Petit F; Garcia T; Marchandeau C; Gronemeyer H; Resche-Rigon M
    Mol Endocrinol; 1997 Aug; 11(9):1245-55. PubMed ID: 9259316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of glucocorticoids on gene transcription.
    Hayashi R; Wada H; Ito K; Adcock IM
    Eur J Pharmacol; 2004 Oct; 500(1-3):51-62. PubMed ID: 15464020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.